Skip to main content
. 2023 Feb 20;14:1078205. doi: 10.3389/fphar.2023.1078205

FIGURE 2.

FIGURE 2

Dapagliflozin ameliorates H/R-induced ROS and lipid peroxidation in H9C2 cells. (A–C) Representative fluorescence images of ROS and DHE staining (scale bar, 100 μM) and quantification of fluorescence intensity (n = 4, 5 per group). (D–F) The levels of lipid ROS were captured by using 2,7-dichlorofluorescein diacetate, oxidized lipids were captured by using C11 BODIPY and measured by flow cytometry in H9C2 cells pretreated with or without DAPA (n = 6 per group). (G) MDA content was assayed by a commercial kit (n = 4 per group). (H) The mRNA level of ACSL4 was measured by qPCR (n = 6 per group). (I) The protein level was measured by western blotting after treatment with 2.5 or 5 μM DAPA (n = 5 per group). Data are expressed as mean ± SD; One-way ANOVA followed by Tukey’s correction for post hoc multiple comparisons or Dunnett’s multiple comparison tests; #p < 0.05, ##p < 0.01 vs Control group; *p < 0.05, **p < 0.01 vs H/Rgroup.